Suppr超能文献

大电导钙激活钾通道(BKCa通道)激活有助于钾通道开放剂诱导猪冠状动脉舒张的证据。

Evidence that BKCa channel activation contributes to K+ channel opener induced relaxation of the porcine coronary artery.

作者信息

Balwierczak J L, Krulan C M, Kim H S, DelGrande D, Weiss G B, Hu S

机构信息

Research Department, Ciba-Geigy Corp., Summit, NJ 07901, USA.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug;352(2):213-21. doi: 10.1007/BF00176777.

Abstract

The rank order of potency of a series of benzopyran and cyanoguanidine K+ channel openers (KCOs) for causing relaxation of the PGF2 alpha-precontracted porcine coronary artery was determined. Glyburide, an inhibitor of KATP channels, showed an apparent competitive inhibition of the vasorelaxant activity of the KCOs. The pA2 values of glyburide when cromakalim and CGP 14877 (P1060) were used as vasorelaxants were 7.66 and 7.83, respectively. Charybdotoxin (40 nM), an inhibitor of BKCa channels, also caused a significant inhibition of the cromakalim mediated relaxation of the porcine coronary artery. In order to clarify the site of action of these KCOs, we identified a K+ channel current in single porcine coronary arterial cells and measured channel activity in the presence of these compounds. The prominent K+ ion current in these cells had characteristics typical of the conventional large Ca(2+)-activated K+ channel (BKCa) present in other smooth muscle cells. Using symmetrical K+ concentrations, the channel had a conductance of 214 pS and was found to be sensitive to [Ca2+]i and membrane potential. The KCOs were found to reversibly increase the open probability (P(o)) of the channel without changing channel conductance. The potency of the KCOs to increase K+ channel opening was similar to the potency of these compounds to cause coronary artery relaxation. These results indicate that the porcine coronary artery contains the BKCa channel and that this channel, along with other types of K+ channels (KATP), mediate the vasorelaxant effects of K+ channel openers.

摘要

测定了一系列苯并吡喃和氰基胍钾通道开放剂(KCOs)使PGF2α预收缩的猪冠状动脉舒张的效价顺序。格列本脲是一种KATP通道抑制剂,对KCOs的血管舒张活性表现出明显的竞争性抑制作用。当用克罗卡林和CGP 14877(P1060)作为血管舒张剂时,格列本脲的pA2值分别为7.66和7.83。大电导钙激活钾通道(BKCa)抑制剂蝎毒素(40 nM)也显著抑制了克罗卡林介导的猪冠状动脉舒张。为了阐明这些KCOs的作用位点,我们在单个猪冠状动脉细胞中鉴定了一种钾通道电流,并在这些化合物存在的情况下测量了通道活性。这些细胞中突出的钾离子电流具有其他平滑肌细胞中存在的传统大电导钙激活钾通道(BKCa)的典型特征。在对称钾浓度条件下,该通道的电导为214 pS,且对细胞内钙离子浓度([Ca2+]i)和膜电位敏感。发现KCOs可逆地增加通道的开放概率(P(o)),而不改变通道电导。KCOs增加钾通道开放的效价与这些化合物引起冠状动脉舒张的效价相似。这些结果表明,猪冠状动脉含有BKCa通道,并且该通道与其他类型的钾通道(KATP)一起介导钾通道开放剂的血管舒张作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验